Antimicrobial Peptide Therapeutics for Cystic Fibrosis

Greater than 90% of lung infections in cystic fibrosis (CF) patients are caused by Pseudomonas aeruginosa, and the majority of these patients subsequently die from lung damage. Current therapies are either targeted at reducing obstruction, reducing inflammation, or reducing infection. To identify po...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Zhang, Lijuan, Parente, Jody, Harris, Scott M., Woods, Donald E., Hancock, Robert E. W., Falla, Timothy J.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2005
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1168697/
https://ncbi.nlm.nih.gov/pubmed/15980369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.49.7.2921-2927.2005
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky